MBBS (University of Sydney, Australia)
MScPH (London School of Hygiene and Tropical Medicine, London, UK)
DTM&H (London School of Hygiene and Tropical Medicine, London, UK)
PhD (UNSW, Sydney, Australia)
Louise is a medical epidemiologist and senior lecturer at The Kirby Institute. She has interest and experience across a number of international public health issues, primarily those with an infectious disease focus including HIV, sexually transmissible infections (STIs) and malaria.
Louise completed her PhD in 2016 at the Kirby Institute UNSW and her work focuses on evaluations of point-of-care (POC) diagnostics for STIs. Louise was a co-investigator on the NHMRC-funded TTANGO trial [Test, Treat and Go] – a large, multisite, randomised controlled trial to evaluate the impact, cost-effectiveness, feasibility and acceptability of a new molecular based point-of-care (POC) test for chlamydia and gonorrhoea in remote community across Australia. The TTANGO2 program builds upon the findings of the trial and is now underway, scaling up POC testing for STIs in remote and regional communities across 4 jurisdictions in Australia.
Prior to joining UNSW, Louise held positions as a medical epidemiologist and Epidemic Intelligence Service Officer (EIS) at the US Centres for Disease Control and Prevention (CDC), medical officer to the polio eradication program at the World Health Organisation (Bangladesh), and research assistant at the UK National Heart Forum and European Centre on Health for Societies in Transition (ECOHOST). Louise completed her clinical medical training with positions in Australia and USA.
Louise has a long standing interest and passion working and conducting research in the field of infectious diseases (including malaria, tuberculosis, HIV and other STIs). Her focus in recent years has been on STIs, including syphilis, chlamydia and gonorrhoea and the potential role and impact for POC tests in remote communities across Australia, PNG and other resource limited settings.
In order for POC tests to be considered for programmatic implementation they must demonstrate accuracy, reliability, acceptability and cost effectiveness in the required setting. Current and future collaborative work with colleagues in Australia and in the Asia Pacific region will evaluate new POC diagnostic platforms for STIs including syphilis, chlamydia, gonorrhoea and trichomonas and investigate the feasibility and scale up of their use in a variety of settings.
Broad Research Areas
Global Health, Infectious Diseases, HIV, STIs, POC diagnostics, operational research, implementation science
MBBS, MScPH, DTM&H, PhD
Specific Research Keywords
STI diagnosis; Point-of-care testing; syphilis; chlamydia; gonorrhoea; Indigenous health; remote Australia
NHMRC PhD Scholarship (2013-2015)
NHMRC Early Career Research Fellowship (2019 - 2022)
NHMRC Research Excellence Award - Frank Fenner Early Career Fellowship 2018
NSW Premiers Prize, Science and Engineering - Early Career Researcher of the Year (Biological Sciences) 2021
My Research Supervision
2019 - 22: PhD candidate - "Evaluating novel approaches to reduce Trichomonas infection rates in remote Aboriginal communities in Australia: a program science approach"
2019 -20: Kirby Institute CHART (Cooper HIV AIDS Research Training) program - "Risk factors associated with syphilis infection among MSM at an urban clinic in Indonesia"
2019: Medicine ILP student - "If you can't make it, your not tough enough to do Medicine"
2019 - Kirby Institute Cooper HIV AIDS Research Training (CHART) Program - Course convenor, lecturer and mentor
2020 - Medicine Phase 1 Facilitator (TP2 BGD)